Chromatin accessibility uncovers KRAS-driven FOSL2 promoting pancreatic ductal adenocarcinoma progression through up-regulation of CCL28.

Authors:
Zhang S; Li P; Li J; Gao J; Qi Q and 8 more

Journal:
Br J Cancer

Publication Year: 2023

DOI:
10.1038/s41416-023-02313-y

PMCID:
PMC10403592

PMID:
37380804

Journal Information

Full Title: Br J Cancer

Abbreviation: Br J Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"we obtained available scrna-seq data of pdac samples from the genome sequence archive under project prjca001063 and accession number cra001160 ( https://ngdc cncb ac cn/search/?; the accession numbers for the bulk atac-seq h3k27ac chip-seq rna-seq and fosl2 cut&tag reported in this paper are gse190900 gse190901 gse190903 and gse190912 respectively. data availability the sequencing data were uploaded to geo. the accession numbers for the bulk atac-seq h3k27ac chip-seq rna-seq and fosl2 cut&tag reported in this paper are gse190900"

Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This research was supported by the Key Research and Development Program of Shandong Province (2021ZLGX02), Taishan Scholars Climbing Program of Shandong Province (tspd20210323), and Tumour Biomarker Innovation Team Foundation of Jinan City (2019GXRC004, 2021GXRC020)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025